Industry-leading hemp and cannabinoid solutions provider GVB Biopharma unveils high-purity Cannabicitran (CBT) Isolate, broadening its suite of rare cannabinoid offerings. PRINEVILLE, Ore., March 13, 2025 /PRNewswire/ -- GVB Biopharma, a premier developer, manufacturer, and global...
Hence then, the article about gvb biopharma expands product portfolio with launch of premium cbt isolate was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( GVB Biopharma Expands Product Portfolio with Launch of Premium CBT Isolate )
Also on site :
- From Cross-Border Remittance to Financial Asset Management: BiyaPay Explores a New Path for Global Asset Allocation
- Protera Achieves Three Expert Competencies for SAP Solutions, Reinforcing Leadership in Enterprise SAP Transformation
- Vision Marine Technologies Introduces Connected Battery Monitoring App to Expand the Ownership Experience